New heart pill for kids tested against old standard
NCT ID NCT07197372
Summary
This study compares two medications for children with dilated cardiomyopathy, a condition where the heart muscle is weak and enlarged. Researchers want to see if a newer drug (sacubitril/valsartan) works better than the older standard drug (captopril) at improving heart pumping strength and keeping kids out of the hospital. The study will follow 70 children in Egypt for one year, tracking their heart function and overall health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARNI are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.